Brief: 3D Medicines Says CEO Purchased 20,000 Ordinary Shares
04/09/2024 16:24
Sept 4 (Reuters) - 3D Medicines Inc 1244.HK :
* CEO PURCHASED 20,000 ORDINARY SHARES FROM OPEN MARKET FROM
SEPT
3 TO 4
Further company coverage: 1244.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 3D Medicines
See all newsArbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
Brief: 3D Medicines Updates On Arbitration Proceedings Against Sellas Life Sciences
Brief: 3D Medicines Inc Says Envafolimab Supplemental Application Accepted By NMPA
Brief: 3D Medicines Inc Says Zhang Jing Resigns As CFO
Brief: 3D Medicines Says New Drug Application For First-Line Treatment Of Biliary Tract Cancer Of Envafolimab Accepted